ALPINE IMMUNE SCIENCES, INC. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
ALPINE IMMUNE SCIENCES, INC. reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 0 shares for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2018-11-08
- ALPINE IMMUNE SCIENCES, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2018-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2017-09-30 was 1.00M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month |
|---|---|---|
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-08 | 0.00 shares 10-Q · filed 2018-11-08 |
| 2017-09-30 | 1.00M shares 10-Q · filed 2018-11-08 | 0.00 shares 10-Q · filed 2018-11-08 |